Loading clinical trials...
Loading clinical trials...
An Open-Label Clinical Study to Evaluate the Safety and Effect of RLS-1496 Topical Cream for the Treatment of Actinic Keratosis
Conditions
Interventions
RLS-1496 1.0% cream
Locations
4
United States
Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
Minnesota Clinical Study Center
New Brighton, Minnesota, United States
Schlessinger MD Skin Research Center
Omaha, Nebraska, United States
Austin Institute for Clinical Research
Pflugerville, Texas, United States
Start Date
January 1, 2026
Primary Completion Date
April 1, 2026
Completion Date
May 1, 2026
Last Updated
January 27, 2026
NCT06648447
NCT07286318
NCT07290959
Lead Sponsor
Rubedo Life Sciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions